Content about Sydney

May 17, 2013

A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.

SYDNEY — A Food and Drug Administration panel will consider whether to recommend approval for an experimental painkiller in July, the drug's developer said Friday.

Australia-based QRxPharma said the FDA had determined that an advisory committee would meet on July 17 to consider a resubmitted application for Moxduo, an immediate-release formulation of the opioid painkillers morphine and oxycodone.

March 27, 2013

Soho Flordis International recently launched Calorease, formulated with a patented fat binder called FBCx, into the U.S. market.

SYDNEY, Australia — Soho Flordis International recently launched Calorease, formulated with a patented fat binder called FBCx, into the U.S. market. 

The dietary fiber used by Calorease, binds up to nine times its weight in fat from food, safely removing it from the body before it can be absorbed. Taken with each meal, Calorease can reduce dietary fat by up to 15,000 calories per month without the restrictions of a low fat diet. 

January 24, 2013

A new strain of norovirus from Australia accounts for more than half of outbreaks around the country, according to the Centers for Disease Control and Prevention.

NEW YORK — A new strain of norovirus from Australia accounts for more than half of outbreaks around the country, according to the Centers for Disease Control and Prevention.

July 18, 2011

Australian drug maker QRxPharma is seeking approval for a drug that combines two painkillers in one pill, the company said Monday.

SYDNEY — Australian drug maker QRxPharma is seeking approval for a drug that combines two painkillers in one pill, the company said Monday.

QRxPharma announced that it had filed a regulatory approval application with the Food and Drug Administration for MoxDuo IR (morphine and oxycodone). The drug is designed to release both drugs into the body immediately.